Thrombin causes cell spreading and redistribution of β-amyloid immunoreactivity in cultured hippocampal neurons

Journal of Neurochemistry

Volumn 67, Issue 1, 1996, Pages 119-130

  Brewer, Gregory J ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion; Alz 50; Amyloid precursor protein; Thrombin receptor

Indexed keywords

AMYLOID BETA PROTEIN; THROMBIN;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL SPREADING; CELLULAR DISTRIBUTION; FEMALE; FLUORESCENCE MICROSCOPY; HIPPOCAMPUS; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RAT;

ANIMALIA;

EID: 0029938079     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67010119.x     Document Type: Article

References (77)

1. Akiyama H., Ikeda K., Kondo H., and McGeer P. L. (1992) Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci. Lett. 146, 152-154.
2. Allinquant B., Moya K. L., Bouillot C., and Prochiantz A. (1994) Amyloid precursor protein in cortical neurons: coexistence of two pools differentially distributed in axons and dendrites and association with cytoskeleton. J. Neurosci. 14, 6842-6854.
3. Aoyagi T., Wada T., Kojima F., Nagai M., Harada S., Takeuchi T., Isse K., Ogura M., Hamamoto M., Tanaka K., and Nagao T. (1992) Deficiency of fibrinolytic enzyme activities in the serum of patients with Alzheimer-type dementia. Experientia 48, 656-659.
4. Aoyagi T., Wada T., Kojima F., Nagai M., Harada S., and Takeuchi T. (1994) Age-dependent decreases in fibrinolytic enzyme activities in serum of healthy subjects. Biol. Pharm. Bull 17, 348-351.
5. Bauer J., Strauss S., Schreitergasser U., Ganter U., Schlegel P., Witt I., Yolk B., and Berger M. (1991) Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285, 111-114.
6. Beecher K. L., Andersen T. T., Fenton J. W., and Festoff B. W. (1994) Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture. J. Neurosci. Res. 37, 108-115.
7. Bowser R., Giambrone A., and Davies P. (1995) FAC1, a novel gene identified with the monoclonal antibody Alz50, is developmentally regulated in human brain. Dev. Neurosci. 17, 20-37.
8. Brewer G. J. (1995) Exogenous thrombin inhibits neuritogenesis in cultured neuroblastoma cells but not in rat hippocampal neurons. Brain Res. 683, 258-263.
9. Brewer G. J. and Ashford J. W. A. (1992) Human serum induces Alzheimer markers in cultured hippocampal neurons. J. Neurosci. Res. 33, 355-369.
10. Brewer G. J., Torricelli J. R., Evege E. K., and Price P. J. (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free combination. J. Neurosci. Res. 35, 567-576.
11. Brezniak D. V., Brower M. S., Witting J. I., Walz D. A., and Fenton J. W. (1990) Human alpha- to eta-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retained. Biochemistry 29, 3536-3542.
12. Buxbaum J. D., Gandy S. E., Cicchetti P., Ehrlich M. E., Czernik A. J., Fracasso R. P., Ramabhadran T. V., Unterbeck A. J., and Greengard P. (1990) Processing of Alzheimer beta-A4 amyloid precursor protein-modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. USA 87, 6003-6006.
13. Buxbaum J. D., Oishi M., Chen H. I., Pinkas-Kramarski R., Jaffee E. A., Gandy S. E., and Greengard P. (1992) Cholinergic agonists and interleukin 1 regulate processing of the Alzheimer beta/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89, 10075-10078.
14. Cataldo A. M. and Nixon R. A. (1990) Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc. Natl. Acad. Sci. USA 87, 3861-3865.
15. Cataldo A. M., Barnett J. L., Berman S. A., Li J., Quarless S., Bursztajn S., Lippa C., and Nixon R. A. (1995) Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14, 671-680.
16. Cavanaugh K., Gurwitz D., Cunningham D., and Bradshaw R. (1990) Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J. Neurochem. 54, 1735-1743.
17. Choi B. H., Kim R. C., Vaughan P. J., Lau A., Van Nostrand W. E., Cotman C. W., and Cunningham D. D. (1995) Decreases in protease nexins in Alzheimer's disease brain. Neurobiol. Aging 16, 557-562.
18. Chong Y. H., Jung J. M., Choi W., Park C. W., Choi K. S., and Suh Y. H. (1994) Bacterial expression, purification of full length and carboxyl terminal fragment of Alzheimer amyloid precursor protein and their proteolytic processing by thrombin. Life Sci. 54, 1259-1268.
19. Cole G. M., Galasko D., Shapiro I. P., and Saitoh T. (1990) Stimulated platelets release amyloid beta-protein precursor. Biochem. Biophys. Res. Commun. 170, 288-296.
20. Davis-Salinas J., Saporito-Irwin S. M., Donovan F. M., Cunningham D. D., and Van Nostrand W. E. (1994) Thrombin receptor activation induces secretion and nonamyloidogenic processing of amyloid beta-protein precursor. J. Biol. Chem. 269, 22623-22627.
21. Dihanich M., Kaser M., Reinhard E., Cunningham D., and Monard D. (1991) Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6, 575-581.
22. Estus S., Golde T. E., Kunishita T., Blades D., Lowery D., Eisen M., Usiak M., Qu X., Tabira T., Greenberg B. D., and Younkin S. G. (1992) Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255, 726-728.
23. Fenton J. W., Fasco M. J., and Stackrow A. B. (1977) Human thrombin. J. Biol. Chem. 252, 3587-3598.
24. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., and Penniman E. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523-527.
25. Ganter U., Strauss S., Jonas U., Weidemann A., Beyreuther K., Volk B., Berger M., and Bauer J. (1991) Alpha-2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells-potential significance for the processing of Alzheimer beta-amyloid precursor protein. FEBS Lett. 282, 127-131.
26. Geddes J. W., Anderson K. J., and Cotman C. W. (1986) Senile plaques as aberrant sprout-stimulating structures. Exp. Neurol. 94, 767-776.
27. Guenther J., Nick H., and Monard D. (1985) A glia-derived neurite-promoting factor with protease inhibitory activity. EMBO J. 4, 1963-1966.
28. Gurwitz D. and Cunningham D. D. (1988) Thrombin modulates and reverses, neuroblastoma neunte outgrowth. Proc. Natl. Acad. Sci. USA 85, 3440-3444.
29. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B., and Selkoe D. J. (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
30. Hartwig J. H., Bokoch G. M., Carpenter C. L., Janmey P. A., Taylor L. A., Toker A., and Stossel T. P. (1995) Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 82, 643-653.
31. Honig M. G. and Hume R. I. (1989) DiI and DiO: versatile fluorescent dyes for neuronal labelling and pathway tracing. Trends Neurosci. 9, 333-340.
32. Hoxie J. A., Ahuja M., Belmonte E., Pizarro S., Parton R., and Brass L. F. (1993) Internalization and recycling of activated thrombin receptors. J. Biol. Chem. 268, 13756-13763.
33. Hung A. Y., Koo E. H., Haass C., and Selkoe D. J. (1992) Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage. Proc. Natl. Acad. Sci. USA 89, 9439-9443.
34. Igarashi K., Murai H., and Asaka J. (1992) Proteolytic processing of amyloid beta-protein precursor (APP) by thrombin. Biochem. Biophys. Res. Commun. 185, 1000-1004.
35. Jesty J. (1986) The kinetics of inhibition of alpha-thrombin in human plasma. J. Biol. Chem. 261, 10313-10318.
36. Jones K. H. and Senft J. A. (1985) An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J. Histochem. 33, 77-79.
37. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzexchik K. H., Multhaup G., Beyreuther K., and Muller-Hill B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-737.
38. Kim K. S., Miller D. L., Chen C. M., Sapienza V. J., Bai C., Grundke-Iqbal I., Currie J. R., and Wisniewski H. M. (1988) Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Commun. 2, 121-130.
39. Kitamoto T., Ogomori K., Tateishi J., and Prusiner S. (1987) Methods in laboratory investigation: formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab. Invest. 57, 230-236.
40. Klier F. G., Cole G., Stallcup W., and Schubert D. (1990) Amyloid beta-protein precursor is associated with extracellular matrix. Brain Res. 515, 336-342.
41. LaFerla F. M., Tinkle B. T., Bieberich C. J., Haudenschild C. C., and Jay G. (1995) The Alzheimer's A-beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet. 9, 21-30.
42. Li Q., Evin G., Small D. H., Multhaup G., Beyreuther K., and Masters C. L. (1995) Proteolytic processing of Alzheimer's disease betaA4 amyloid precursor protein in human platelets. J. Biol. Chem. 270, 14140-14147.
43. Liu Y., Fields R. D., Festoff B. W., and Nelson P. G. (1994) Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc. Natl. Acad. Sci. USA 91, 10300-10304.
44. Masliah E., Mallory M., Ge N. F., and Saitoh T. (1992) Amyloid precursor protein is localized in growing neuntes of neonatal rat brain. Brain Res. 593, 323-328.
45. Mortimer J. A., Vanduijn C. M., Chandra V., Fratiglioni L., Graves A. B., Heyman A., Jorm A. F., Kikmen E., Kondo K., Rocca W. A., Shalat S. L., Soininen H., and Hofman A. (1991) Head trauma as a risk factor for Alzheimer's disease - a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20 (Suppl.), S28-S35.
46. Naidu A., Quon D., and Cordell B. (1995) Beta-amyloid peptide produced in vitro is degraded by proteinases released by cultured cells. J. Biol. Chem. 270, 1369-1374.
47. Nelson R. and Siman R. (1990) Thrombin and its inhibitors regulate morphological and biochemical differentiation of astrocytes in vitro. Dev. Brain Res. 54, 93-104.
48. Ninomiya H., Roch J.-M., Jin L.-W., and Saitoh T. (1994) Secreted form of amyloid beta/A4 protein precursor (APP) binds to two distinct APP binding sites on rat B103 neuron-like cells through two different domains, but only one site is involved in neuritotropic activity. J. Neurochem. 63, 495-500.
49. Nishino A., Suzuki M., Ohtani H., Motohashi O., Umezawa K., Nagura H., and Yoshimoto T. (1993) Thrombin may contribute to the pathophysiology of central nervous system injury. J. Neurother. 10, 167-179.
50. Pumiglia K. M. and Feinstein M. B. (1993) Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton - translocation of pp60(c-src) and integrin alpha(IIb)beta(3) (glycoprotein IIb/ IIIa) is not required for aggregation, but is dependent on formation of large aggregate structures. Biochem. J. 294, 253-260.
51. 2+ mobilization. FEBS Lett. 288, 123-128.
52. Roberts G. W., Gentleman S. M., Lynch A., Murray L., Landon M., and Graham D. I. (1994) Beta amyloid protein deposition in the brain after severe head injury - implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 57, 419-425.
53. Rosenblatt D. E., Geula C., and Mesulam M. M. (1989) Protease nexin I immunostaining in Alzheimer's disease. Ann. Neurol. 26, 628-634.
54. Saito K. I., Elce J. S., Hamos J. E., and Nixon R. A. (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease - a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. USA 90, 2628-2632.
55. Schagger H. and Von Jagow G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 KDa. Anal. Chem. 166, 368-379.
56. Schubert D., Jin L. W., Saitoh T., and Cole G. (1989a) The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion. Neuron 3, 689-694.
57. Schubert D., LaCorbiere M., Saitoh T., and Cole G. (1989b) Characterization of an amyloid β precursor protein that binds heparin and contains tyrosine sulfate. Proc. Natl. Acad. Sci. USA 86, 2066-2069.
58. Shivers B. D., Hilbich C., Multhaup G., Salbaum M., Beyreuther K., and Seeburg P. H. (1988) Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J. 7, 1365-1370.
59. Simpson C., Johnson H., and Morris B. (1994) Neuronal expression of protease-nexin I mRNA in rat brain. Neurosci. Lett. 170, 286-290.
60. Smith M. A. and Perry G. (1994) Alzheimer disease - an imbalance of proteolytic regulation. Med. Hypotheses 42, 277-279.
61. Smith R. P. and Braze G. J. (1992) Characterization of platelet-releasable forms of beta-amyloid precursor proteins-the effect of thrombin. Blood 80, 2252-2260.
62. Smith-Swintosky V. L., Zimmer S., Fenton J. W. II, and Mattson M. P. (1995a) Opposing actions of thrombin and protease nexin-1 on amyloid beta-peptide toxicity and on accumulation of peroxides and calcium in hippocampal neurons. J. Neurochem. 65, 1415-1418.
63. 2+ homeostasis and sensitivity to glucose deprivation-induced injury. J. Neurosci. 15, 5840-5850.
64. Strauss S., Bauer J., Ganter U., Jonas U., Berger M., and Volk B. (1992) Detection of interleukin-6 and alpha2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66, 223-230.
65. Suidan H. S., Stone S. R., Hemmings B. A., and Monard D. (1992) Thrombin causes neunte retraction in neuronal cells through activation of cell surface receptors. Neuron 8, 363-375.
66. Suzuki M., Motohashi O., Nishino A., Shiina V., Mizoi K., Yoshimoto T., Kameyama M., and Onuma T. (1994) Diphasic increase in thrombin-antithrombin-III complex in blood from the internal jugular vein following severe head injury. Thromb. Haemost. 71, 155-157.
67. Vaughan P. J., Pike C. J., Cotman C. W., and Cunningham D. D. (1995) Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 15, 5389-5401.
68. Vu T. K. H., Hung D. T., Wheaton V. I., and Coughlin S. R. (1991a) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068.
69. Vu T. K. H., Wheaton V. I., Hung D. T., Charo I., and Coughlin S. R. (1991b) Domains specifying thrombin-receptor interaction. Nature 353, 674-677.
70. Wagner S. L., Geddes J. W., Cotman C. W., Lau A. L., Gurwitz D., Isackson P. J., and Cunningham D. D. (1989) Protease nexin-1, an antithrombin with neunte outgrowth activity, is reduced in Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 8284-8288.
71. Wasco W., Bupp K., Magendantz M., Gusella J. F., Tanzi R. E., and Solomon F. (1992) Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid-beta-protein precursor. Proc. Natl. Acad. Sci. USA 89, 10758-10762.
72. Wattendorff A. R., Frangione B., Luyendijk W., and Boss G. T. A. M. (1995) Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D): clinicopathological studies. J. Neurol. Neurosurg. Psychiatry 58, 699-705.
73. Weidemann A., Konig G., Bunke D., Fischer P., Salbaum J. M., Masters C. L., and Beyreuther K. (1989) Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57, 115-126.
74. Weinstein J. R., Gold S. J., Cunningham D. D., and Gall C. M. (1995) Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J. Neurosci. 15, 2906-2919.
75. Wisniewski H. M., Vorbrodt A. W., Wegiel J., Morys J., and Lossinsky A. S. (1990) Ultrastructure of the cells forming amyloid fibers in Alzheimer disease and scrapie. Am. J. Med. Genet. Suppl. 7, 287-297.
76. Wojtukiewicz M., Tang D., Nelson K., Walz D., Diglio C., and Honn K. (1992) Thrombin enhances tumor cell adhesive and metastatic properties via increased alphaIIb-beta3 expression on the cell surface. Thromb. Res. 68, 233-245.
77. Wolozin B. L., Pruchnicki A., Dickson D. W., and Davies P. (1986) A neuronal antigen in the brains of Alzheimer patients. Science 232, 648-650.